Mark D. Ewalt

1.8k total citations
31 papers, 340 citations indexed

About

Mark D. Ewalt is a scholar working on Genetics, Hematology and Cancer Research. According to data from OpenAlex, Mark D. Ewalt has authored 31 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Hematology and 9 papers in Cancer Research. Recurrent topics in Mark D. Ewalt's work include Acute Myeloid Leukemia Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Mark D. Ewalt is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Mark D. Ewalt collaborates with scholars based in United States, Canada and Qatar. Mark D. Ewalt's co-authors include Dita Gratzinger, Annette S. Kim, Rebecca F. McClure, Or Gozani, Colin G. Ferguson, Junying Yuan, Mrudula Pullambhatla, Robyn Temple‐Smolkin, Jennifer Crow and Glenn D. Prestwich and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark D. Ewalt

27 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Ewalt United States 12 137 132 124 62 57 31 340
Penny Wright United Kingdom 10 162 1.2× 219 1.7× 101 0.8× 83 1.3× 57 1.0× 13 402
Pascaline Etancelin France 9 154 1.1× 107 0.8× 125 1.0× 162 2.6× 50 0.9× 27 360
Tuija Lundán Finland 8 95 0.7× 109 0.8× 109 0.9× 87 1.4× 32 0.6× 18 293
Ilaria Silvestris Italy 9 68 0.5× 124 0.9× 98 0.8× 70 1.1× 36 0.6× 23 281
Mathew W. Ludgate New Zealand 5 73 0.5× 119 0.9× 34 0.3× 36 0.6× 42 0.7× 5 338
Eva Arranz Spain 14 252 1.8× 162 1.2× 172 1.4× 231 3.7× 71 1.2× 24 545
Alessia Tabarrini Italy 8 228 1.7× 209 1.6× 133 1.1× 115 1.9× 16 0.3× 9 493
Patrik Andreasson Sweden 9 259 1.9× 141 1.1× 99 0.8× 40 0.6× 32 0.6× 13 425
Julie C. Porcher United States 8 65 0.5× 106 0.8× 71 0.6× 213 3.4× 54 0.9× 13 399

Countries citing papers authored by Mark D. Ewalt

Since Specialization
Citations

This map shows the geographic impact of Mark D. Ewalt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Ewalt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Ewalt more than expected).

Fields of papers citing papers by Mark D. Ewalt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Ewalt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Ewalt. The network helps show where Mark D. Ewalt may publish in the future.

Co-authorship network of co-authors of Mark D. Ewalt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Ewalt. A scholar is included among the top collaborators of Mark D. Ewalt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Ewalt. Mark D. Ewalt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stuver, Robert, Ting Zhou, Michael Zaidinski, et al.. (2024). A Novel JAK2 Fusion in T‐Cell Prolymphocytic Leukemia. Genes Chromosomes and Cancer. 63(6). e23252–e23252.
2.
Winters, Amanda, Mohd Minhajuddin, Brett M. Stevens, et al.. (2023). Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine. Haematologica. 109(6). 1766–1778. 5 indexed citations
3.
Nocco, Sarah E., Mark D. Ewalt, Andrea P. Moy, et al.. (2023). TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases. Journal of the American Academy of Dermatology. 90(4). 839–841. 4 indexed citations
4.
Argyropoulos, Kimon V., Umut Aypar, Mark D. Ewalt, et al.. (2023). Chronic lymphocytic leukemia transdifferentiated to blastic neoplasm with T/plasmacytoid dendritic cell immunophenotype. Leukemia & lymphoma. 64(3). 734–737.
5.
Craven, Kelly E. & Mark D. Ewalt. (2023). Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance). Clinics in Laboratory Medicine. 43(4). 565–576. 3 indexed citations
6.
Aypar, Umut & Mark D. Ewalt. (2022). A very Burkitt-like case of Burkitt-like lymphoma with 11q aberration. Blood. 139(11). 1771–1771. 1 indexed citations
7.
Velu, Priya, Allison M. Cushman‐Vokoun, Mark D. Ewalt, et al.. (2022). Alignment of Fellowship Training with Practice Patterns for Molecular Pathologists. Journal of Molecular Diagnostics. 24(8). 825–840. 1 indexed citations
8.
Hou, Yanli, Krishna M. Roskin, Daniel A. Arber, et al.. (2021). Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance. Blood Advances. 5(17). 3492–3496. 14 indexed citations
9.
Rosenbaum, Jason N., Anna B. Berry, Alanna J. Church, et al.. (2021). A Curriculum for Genomic Education of Molecular Genetic Pathology Fellows. Journal of Molecular Diagnostics. 23(10). 1218–1240. 2 indexed citations
10.
Beck, Rose, Annette S. Kim, Rashmi S. Goswami, et al.. (2020). Molecular/Cytogenetic Education for Hematopathology Fellows. American Journal of Clinical Pathology. 154(2). 149–177. 5 indexed citations
11.
Ewalt, Mark D., et al.. (2020). Hemophagocytic syndrome–associated intravascular large B-cell lymphoma. Blood. 135(26). 2432–2432.
12.
McClure, Rebecca F., Mark D. Ewalt, Jennifer Crow, et al.. (2018). Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms. Journal of Molecular Diagnostics. 20(6). 717–737. 41 indexed citations
13.
Soderquist, Craig, Mark D. Ewalt, David R. Czuchlewski, et al.. (2018). Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Modern Pathology. 31(5). 690–704. 27 indexed citations
14.
Zhai, Jing, et al.. (2018). Molecular characterization of metaplastic breast carcinoma via next-generation sequencing. Human Pathology. 86. 85–92. 26 indexed citations
15.
Hsiao, Susan J., Dara L. Aisner, & Mark D. Ewalt. (2018). Clinical Next-Generation Sequencing Assays for Solid Tumors. 1(1). 167–182. 1 indexed citations
16.
Ozawa, Michael G., Mark D. Ewalt, & Dita Gratzinger. (2015). Dasatinib-related Follicular Hyperplasia. The American Journal of Surgical Pathology. 39(10). 1363–1369. 15 indexed citations
17.
Ewalt, Mark D., Janaki Abeynayake, Jesse J. Waggoner, Benjamin A. Pinsky, & Robert S. Ohgami. (2013). Profound plasmacytosis in a patient with dengue. International Journal of Hematology. 98(5). 518–519. 1 indexed citations
18.
Galili, Naomi, Владимир Трифонов, Mark D. Ewalt, et al.. (2012). Identification of Dido1 Mutation Associated with Familial Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML). Blood. 120(21). 169–169. 3 indexed citations
19.
Gozani, Or, Seth J. Field, Colin G. Ferguson, et al.. (2005). Modification of protein sub-nuclear localization by synthetic phosphoinositides: Evidence for nuclear phosphoinositide signaling mechanisms. Advances in Enzyme Regulation. 45(1). 171–185. 12 indexed citations
20.
Elkin, Sheryl K., Dmitri Ivanov, Mark D. Ewalt, et al.. (2005). A PHD Finger Motif in the C Terminus of RAG2 Modulates Recombination Activity. Journal of Biological Chemistry. 280(31). 28701–28710. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Penny Wright Breakdown of academic impact, for papers by Pascaline Etancelin Breakdown of academic impact, for papers by Tuija Lundán Breakdown of academic impact, for papers by Ilaria Silvestris Breakdown of academic impact, for papers by Mathew W. Ludgate Breakdown of academic impact, for papers by Eva Arranz Breakdown of academic impact, for papers by Alessia Tabarrini Breakdown of academic impact, for papers by Patrik Andreasson Breakdown of academic impact, for papers by Julie C. Porcher
Rankless by CCL
2026